Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma

被引：0
|
作者：
Yudai Ishiyama
Tsunenori Kondo
Hidekazu Tachibana
Hiroki Ishihara
Hironori Fukuda
Kazuhiko Yoshida
Toshio Takagi
Junpei Iizuka
Kazunari Tanabe
机构：
[1] Tokyo Women’s Medical University Medical Center East,Department of Urology
[2] Tokyo Women’s Medical University,Department of Urology
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Metastatic kidney cancer; Biomarkers; Immunotherapy; Immune-checkpoint inhibitor; Prognosticator;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：552 / 561
页数：9
相关论文
共 50 条
  • [31] Renal allograft rejection after treatment with nivolumab in patients with metastatic renal cell carcinoma
    Gaku Ishikawa
    Takayuki Sugiyama
    Toshiki Ito
    Atsushi Otsuka
    Hideaki Miyake
    International Cancer Conference Journal, 2021, 10 : 116 - 118
  • [32] TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma
    Albiges, L.
    Barthelemy, P.
    Gross-Goupil, M.
    Negrier, S.
    Needle, M. N.
    Escudier, B.
    ANNALS OF ONCOLOGY, 2021, 32 (01) : 97 - 102
  • [33] Prognostic Factors in Patients Receiving Third Line Targeted Therapy for Metastatic Renal Cell Carcinoma
    Iacovelli, Roberto
    Farcomeni, Alessio
    Sternberg, Cora N.
    Carteni, Giacomo
    Milella, Michele
    Santoni, Matteo
    Cerbone, Linda
    Di Lorenzo, Giuseppe
    Verzoni, Elena
    Ortega, Cinzia
    Sabbatini, Roberto
    Ricotta, Riccardo
    Messina, Caterina
    Lorusso, Vito
    Atzori, Francesco
    De Vincenzo, Fabio
    Sacco, Cosimo
    Boccardo, Francesco
    Valduga, Francesco
    Massari, Francesco
    Baldazzi, Valentina
    Cinieri, Saverio
    Mosca, Alessandra
    Ruggeri, Enzo Maria
    Berruti, Alfredo
    Procopio, Giuseppe
    JOURNAL OF UROLOGY, 2015, 193 (06): : 1905 - 1910
  • [34] Plasma fibrinogen as prognostic predictor in patients with metastatic renal cell carcinoma receiving target therapy
    Wang, Lihe
    Cai, Wen
    Kong, Wen
    Zhang, Jin
    Chen, Yonghui
    Huang, Jiwei
    Huang, Yiran
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (06) : 1384 - 1392
  • [35] Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab
    Zine‐Eddine Khene
    Romain Kokorian
    Romain Mathieu
    Anis Gasmi
    Rioux-Leclercq Nathalie
    Kammerer-Jacquet Solène-Florence
    Shahrokh Shariat
    Renaud de Crevoisier
    Brigitte Laguerre
    Karim Bensalah
    International Journal of Clinical Oncology, 2021, 26 : 2087 - 2093
  • [36] Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab
    Khene, Zine-Eddine
    Kokorian, Romain
    Mathieu, Romain
    Gasmi, Anis
    Nathalie, Rioux-Leclercq
    Solene-Florence, Kammerer-Jacquet
    Shariat, Shahrokh
    de Crevoisier, Renaud
    Laguerre, Brigitte
    Bensalah, Karim
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (11) : 2087 - 2093
  • [37] Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
    Choueiri, Toni K.
    Fishman, Mayer N.
    Escudier, Bernard
    McDermott, David F.
    Drake, Charles G.
    Kluger, Harriet
    Stadler, Walter M.
    Perez-Gracia, Jose Luis
    McNeel, Douglas G.
    Curti, Brendan
    Harrison, Michael R.
    Plimack, Elizabeth R.
    Appleman, Leonard
    Fong, Lawrence
    Albiges, Laurence
    Cohen, Lewis
    Young, Tina C.
    Chasalow, Scott D.
    Ross-Macdonald, Petra
    Srivastava, Shivani
    Jure-Kunkel, Maria
    Kurland, John F.
    Simon, Jason S.
    Sznol, Mario
    CLINICAL CANCER RESEARCH, 2016, 22 (22) : 5461 - 5471
  • [38] An evaluation of nivolumab for the treatment of metastatic renal cell carcinoma
    Zarrabi, Kevin
    Wu, Shenhong
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (06) : 695 - 705
  • [39] Nivolumab undergoing Phase I testing in metastatic renal cell carcinoma patients
    Nagda, Priti
    FUTURE ONCOLOGY, 2013, 9 (08) : 1070 - 1070
  • [40] Inflammatory markers for predicting responses to nivolumab in patients with metastatic renal cell carcinoma
    Ikarashi, Daiki
    Kato, Yoichiro
    Kato, Renpei
    Kanehira, Mitsugu
    Takata, Ryo
    Obara, Wataru
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (04) : 350 - 351
12345